Cannabix Technologies Provides Update on Marijuana Breathalyzer Development
January 23 2018 - 08:40AM
InvestorsHub NewsWire
501-3292 Production Way,
Burnaby, B.C., V5A 4R4
Phone: (604) 551-7831 Fax: 604-676-2767
info@cannabixtechnologies.com
cannabixtechnologies.com
The Cannabix Marijuana
Breathalyzer is being developed to give law enforcement and
employers a tool to enforce public safety.
Vancouver, British
Columbia -- January 23, 2018 -- InvestorsHub NewsWire -- Cannabix
Technologies Inc. (CSE: BLO) (OTC PINK: BLOZF) (the "Company or
Cannabix") developer of the Cannabix Marijuana Breathalyzer for law
enforcement and the workplace, is pleased to report development of
its "Beta 3.0" (Cannabix Marijuana Breathalyzer) prototype device
based on its FAIMS- (field asymmetric
waveform ion mobility spectrometry) has been proceeding at a robust
pace and is now complete. This device is designed to operate both
independently or coupled in tandem directly to a conventional
Quadrupole Mass Spectrometer (MS) device used in forensic
labs.
The Beta 3.0
prototype incorporates several key technological improvements which
include enhancements to the ion source which, for portability,
has been
reduced in size with sustained stability, providing improvements to
transmission and overall device sensitivity. The Beta 3.0 prototype
also incorporates its own tunable self-contained
detector which can be used in both
independent FAIMS operation or in "pass-through"
mode for tandem
coupling directly with a MS device.
Chief Scientific
Officer, Dr. Raj Attariwala,
states, "With completion of the modular
Beta 3.0 prototype, Cannabix has achieved several key developmental
milestones allowing this technology to be directly tested against
the accepted laboratory standard of mass spectrometry".
The
Company has performed preliminary bench testing with the Beta 3.0
prototype and has successfully detected THC using the device in
stand-alone mode with tandem MS analysis demonstrating direct
correlation. This is a significant developmental milestone which
the Company will use to optimize and characterize the device's
performance measures both independently and coupled to
MS.
Cannabix has been on
the leading edge in innovation with FAIMS technology built upon the
current technique of MS for measuring THC. MS is considered the
gold standard in toxicology in the analysis of drugs, poisons, and
metabolites, due to its superior specificity and sensitivity. It is
anticipated that any marijuana breathalyzer product will need to
have its results be secondarily confirmed by independent MS. Recent
work by Company scientists and
engineers to allow the Cannabix Marijuana breathalyzer to easily
couple to conventional MS equipment used in toxicology labs
everywhere is a significant achievement.
About
Cannabix Technologies Inc
Cannabix Technologies
Inc. is a leader in marijuana breathalyzer development for law
enforcement and the workplace. Cannabix
has established breath testing technologies in the pursuit of
bringing durable, portable hand-held tools to market to enhance
detection of marijuana impaired driving offences on roads at a time
when marijuana is becoming legal in many global jurisdictions.
Cannabix is working to develop drug-testing devices that will
detect THC- the psychoactive component of marijuana that causes
intoxication- using breath samples. In particular, Cannabix is
focused on developing breath testing devices for detection of
recent use of THC, in contrast to urine testing for THC metabolite
that requires an invasive collection and reflects use days or even
weeks earlier. The devices will also be useful for other practical
applications such as testing employees in the workplace where
intoxication by THC can be hazardous.
We
seek Safe Harbor.
On behalf of the Board of Directors
"Rav
Mlait"
CEO
Cannabix Technologies
Inc.
For
further information, contact the Company at info@cannabixtechnologies.com
The CSE has not reviewed and does not accept responsibility
for the adequacy or accuracy of this release.
Cautionary Statement
Regarding Forward-Looking Statements
This
press release contains forward-looking information that involves
various risks and uncertainties regarding future events. Such
forward-looking information can include without limitation
statements based on current expectations involving a number of
risks and uncertainties and are not guarantees of future
performance of the Company, such as final development of a
commercial or prototype product(s), successful trial or pilot of
company technologies, no assurance that commercial sales of any
kind actually materialize; no assurance the Company will have
sufficient funds to complete product development. There are
numerous risks and uncertainties that could cause actual results
and the Company's plans and objectives to differ materially from
those expressed in the forward-looking information, including: (i)
adverse market conditions; (ii) risks regarding protection of
proprietary technology; (iii) the ability of the Company to
complete financings; (iv) the ability of the Company to develop and
market its future product; and (v) risks regarding government
regulation, managing and maintaining growth, the effect of adverse
publicity, litigation, competition and other factors which may be
identified from time to time in the Company's public announcements
and filings. There is no assurance that the marijuana breathalyzer
business will provide any benefit to the Company, and no assurance
that any proposed new products will be built or proceed. There is
no assurance that existing "patent pending" technologies licensed
by the Company will receive patent status by regulatory
authorities. The Company is not currently selling commercial
breathalyzers. Actual results and future events could differ
materially from those anticipated in such information. These and
all subsequent written and oral forward-looking information are
based on estimates and opinions of management on the dates they are
made and are expressly qualified in their entirety by this notice.
Except as required by law, the Company does not intend to update
these forward-looking statements.
Cannabix Technologies (PK) (USOTC:BLOZF)
Historical Stock Chart
From Feb 2024 to Mar 2024
Cannabix Technologies (PK) (USOTC:BLOZF)
Historical Stock Chart
From Mar 2023 to Mar 2024